BIOREGULATORY DRUGS FOR ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN
DOI: https://doi.org/10.29296/25877305-2018-03-22
Issue:
3
Year:
2018
Frequent acute respiratory viral infections (6-10 episodes per year) in many children require the use of various medications, which leads to immunological tolerance. Their efficient and cost-effective replacement (or complement to drug therapy) is the combination bioregulatory medications manufactured by the company Heel.
Keywords:
therapy
children
acute respiratory viral infections
bioregulatory drugs
References:
- Briko N.I. Kliniko-epidemiologicheskaja harakteristika grippa i ORVI i napravlenija ih profilaktiki // Meditsinskaja sestra. – 2013; 8: 16–23.
- Bulgakova V.A. Ostrye respiratornye infektsii u detej: ratsional'nyj vybor farmakoterapii // Spravochnik pediatra. – 2011; 8: 28–37.
- Grigor'ev K.I., Vyhristjuk O.F., Rahmetullova G.R. Rekurrentnye respiratornye infektsii u chasto bolejuschih detej // Meditsinskaja sestra. – 2015; 8: 28–34.
- Zaplatnikov A.L., Korovina N.A., Burtseva E.I. Sovremennye preparaty, soderzhaschie sverhmalye dozy dejstvujuschego veschestva, i traditsionnye gomeopaticheskie sredstva v profilaktike i lechenii ORVI i grippa u detej // Pediatrija. – 2009; 87 (1): 95–100.
- Mar'janovskij A.A. Osobennosti kompleksnoj terapii rinosinusitov preparatami na osnove natural'nyh komponentov // RMZh. – 2016; 3: 140–2.